Michael Staton
Co-Founder & CEO @ CoLearn
San Francisco, United States
Michael Staton is a seed investor at CoLearn in San Francisco focused on Genetics and Education. Michael Staton is the Co-Founder and CEO at CoLearn. Michael previously worked at Osmosis.org from Elsevier as a Seed Investor. He attended Clark University.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Michael Staton invests in
Stages Michael Staton invests in
Countries Michael Staton invests in
Investment Focus
Industry
- Genetics 2 (33%)
- Education 2 (33%)
- Biotechnology 2 (33%)
- Nanotechnology 2 (33%)
- Artificial Intelligence 2 (33%)
Stage
- Seed 3 (50%)
- Angel 3 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enki
|
Enki builds AI products for the workforce development and upskilling industry. Offers a dynamic and adaptive educational experience that caters to the evolving needs of professionals seeking to enhance their technical skills. | $1.5M / Seed / Jan 01, 2021 | |
Nana Academy
|
Nana is a vertically integrated student-to-operator trade skills school, today focused on Appliance Repair. We work with some of the 35 million people who will lose their jobs by 2030 to tech automation, teaching them trade skills, building their experience through our mentorship program, and connecting them to good jobs on our marketplace. Byperfecting this pipeline and teaching life skills to a new generation of tradespeople, we are accelerating the retooling of America’s workforce and creating millions of economic opportunities. | $6M / Seed / Nov 12, 2020 | |
Ligandal
|
Ligandal's mission is to create personalized gene therapies to cure disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design ofdiagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to gene editing indications in hematology and immuno-oncology. | $330K / Angel / Aug 09, 2016 | |
Ligandal
|
Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design ofdiagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease. | $330K / Angel / Aug 09, 2016 | |
Apptuto
|
Apptuto is changing the way we learn, combining academic excellence with technical innovation in order to better prepare and connect students globally. Our multi platform software is redefining exam preparation and has initially launched for candidates of the Chartered Financial Analyst CFA® Program. | $500K / Angel / Oct 28, 2015 | |
Plethora
|
Plethora is a manufacturing system that turns customer designs into custom parts using robotics and advanced software. The company's software works alongside CAD and CAM software to make CNC manufacturing more efficient. Plethora was established in 2012 by Jeremy Herrman and Nick Pinkston and it is headquartered in San Francisco, California,. | $1.6M / Seed / Oct 13, 2013 |
Co-Investors
About CoLearn
An easier way to organize the best resources for each child, all in one place. Each learner has a secure link to their own learning plan for a weekly schedule that includes parent instructions.
CoLearn Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Michael Staton
Co-Founder & CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Michael Staton invest in?
Michael Staton invests primarily in Genetics, Education and Biotechnology startups, most often at Seed and Angel stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Michael Staton last invest?
The most recent investment recorded for Michael Staton closed in Jan 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
